Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 6—June 2017
Research

Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients

Jean Y. Douet, Caroline Lacroux, Naima Aron, Mark W. Head, Séverine Lugan, Cécile Tillier, Alvina Huor, Hervé Cassard, Mark Arnold, Vincent Beringue, James W. Ironside, and Olivier AndréolettiComments to Author 
Author affiliations: Institut National de la Recherche Agronomique, Toulouse, France (J.Y. Douet, C. Lacroux, N. Aron, S. Lugan, C. Tillier, A. Huor, H. Cassard, O. Andréoletti); University of Edinburgh, Edinburgh, Scotland, UK (M.W. Head, J.W. Ironside); Animal and Plant Health Agency, Loughborough, UK (M. Arnold); Institut National de la Recherche Agronomique, Jouy-en-Josas, France (V. Beringue)

Main Article

Figure 4

Detection of proteinase K–resistant prions (PrPres) by using Western blotting and paraffin-embedded tissue (PET) blotting of brains of transgenic mice expressing bovine PrP (tgBov). A) PrPres WB of a vCJD sample (frontal cortex), tgBov mice (brain) inoculated with the same vCJD reference isolate, bone marrow samples from vCJD-affected patients (vCJD 1–vCJD-4 [P1–P4]; Table 2), and a non–vCJD control (NC-1; Table 2). A scrapie isolate (WB cont) and a noninoculated tgBov brain (vCJD brain) homogen

Figure 4. Detection of proteinase K–resistant prions (PrPres) by using Western blotting and paraffin-embedded tissue (PET) blotting of brains of transgenic mice expressing bovine PrP (tgBov). A) PrPres WB of a vCJD sample (frontal cortex), tgBov mice (brain) inoculated with the same vCJD reference isolate, bone marrow samples from vCJD-affected patients (vCJD 1–vCJD-4 [P1–P4]; Table 2), and a non–vCJD control (NC-1; Table 2). A scrapie isolate (WB cont) and a noninoculated tgBov brain (vCJD brain) homogenate were included as controls. PrPres immunodetection was performed by using Sha31 monoclonal antibody (epitope 145YEDRYYRE152) and 12B2 epitope (epitope 89WGQGG93). B) PET blotting of PrPres distribution in coronal section (thalamus level) of tgBov mice inoculated with a reference vCJD isolate (10% brain homogenate) or bone marrow (10% tissue homogenate) from 2 vCJD patients (vCJD-1 and vCJD-3; Table 2) at the clinical stage of disease. Immunodetection of PrPres was performed by using Sha31 monoclonal antibody (epitope 145YEDRYYRE152). Cont, control; NI, not inoculated; WB, Western blot. Scale bar indicates 120 μm.

Main Article

Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external